rs2675703 — OPN4

OPN4 Pro10Leu — When Your Eye's Circadian Clock Runs Quieter

Melanopsin is the photopigment that makes you a social animal of time. Unlike the rod and cone photoreceptors that handle vision, melanopsin sits in a specialized subset of retinal ganglion cells — intrinsically photosensitive retinal ganglion cells (ipRGCs)¹¹ intrinsically photosensitive retinal ganglion cells (ipRGCs)
These cells project to the suprachiasmatic nucleus (SCN), the brain's master clock — and has one job: tell your brain what time of day it is based on ambient light. When melanopsin detects morning blue light, it suppresses melatonin, entrains your circadian clock, boosts alertness, and stabilizes mood. The OPN4 Pro10Leu variant (rs2675703) subtly reduces the amplitude of this melanopsin signal, making the clock's light input slightly quieter.

The Mechanism

At position 10 of the melanopsin protein, a proline (Pro) is swapped for leucine (Leu). This P10L substitution is located in the N-terminal intracellular domain of the G protein-coupled receptor. Rodgers et al. 2018²² Rodgers et al. 2018
Human Molecular Genetics, in-vivo rescue study using viral delivery to mouse ipRGCs tested the Pro10Leu variant directly using a mouse melanopsin-knockout model and found that ipRGCs expressing the human P10L variant showed reduced response amplitude compared to wild-type human melanopsin — even though the light sensitivity threshold (EC50) was unchanged. In behavioral tests, circadian photoentrainment and pupillary light responses were functionally rescued, suggesting the variant is not severely disabling. However, the reduced amplitude means the signal generated per photon is smaller, which matters most under dim or brief light exposures — exactly the conditions of winter mornings at higher latitudes.

The Evidence

The key clinical association comes from Roecklein et al. 2009³³ Roecklein et al. 2009
Journal of Affective Disorders, n=130 SAD / 90 controls. SAD participants had a significantly higher frequency of the homozygous T/T genotype: all 7 individuals (5% of the full sample) who carried TT were in the SAD group, yielding an odds ratio of 5.6 for SAD membership. The study also examined haplotypes across multiple OPN4 variants, but rs2675703 P10L was among the most significant individual associations. Importantly, recruitment methods differed between groups, and the result has not been independently replicated for SAD specifically.

The 2012 chronotype study by Roecklein et al.⁴⁴ Roecklein et al.
Chronobiology International, n=234 non-psychiatric community adults found that TT carriers — unlike CC and CT carriers — showed a significant interaction between daylength and sleep onset: TT individuals went to bed later on long days and earlier on short days, while CC/CT carriers showed no such seasonal shift. This suggests the variant doesn't uniformly disrupt sleep but rather changes how sleep timing responds to seasonal light cues.

A pilot study in Mexican individuals (Gutiérrez-Amavizca et al. 2021⁵⁵ Gutiérrez-Amavizca et al. 2021
IJERPH, n=29 insomnia / 98 controls) found a striking association between the T allele and chronic insomnia (dominant model OR=9.37, p=1×10⁻⁴). The confidence intervals are wide (8.18–335.66 for dominant model), reflecting the small sample; this should be considered a preliminary signal requiring replication.

The 2013 pupil study (Roecklein et al.⁶⁶ Roecklein et al.
Psychiatry Research, n=30) found that post-illumination pupil response (PIPR) was reduced in SAD patients overall, but the reduction tracked with the I394T variant (rs11150800), not P10L. This dissociates the two OPN4 variants: I394T primarily affects light sensitivity threshold, while P10L affects signal amplitude.

A 2025 systematic review (Lucio-Enríquez et al.⁷⁷ Lucio-Enríquez et al.
Frontiers in Neuroscience) synthesizing 9 OPN4 studies confirmed that P10L is associated with SAD, chronotype variability, and chronic insomnia — while noting that the overall body of evidence remains small and that insomnia patients with this variant also showed higher rates of obesity or overweight, potentially reflecting circadian disruption downstream effects.

Practical Actions

The melanopsin pathway is unusually amenable to behavioral intervention precisely because its substrate — light — is something you can control. For TT carriers, the implication of reduced melanopsin signal amplitude is that the circadian system may need a stronger or more precisely timed light input to achieve the same photoentrainment signal. Morning bright light exposure (10,000 lux for 20–30 minutes within an hour of waking) is the most evidence-based way to boost the ipRGC signal, and this is the same intervention used clinically for SAD. Evening blue-light blocking (using amber lenses or screen filters after sunset) reduces competitive melanopsin activation that would otherwise delay the melatonin onset.

CT heterozygotes have a less clear phenotype — most studies grouped CC and CT together as the non-TT reference — but some evidence suggests mild seasonal sleep timing variability. Awareness of this tendency allows proactive adjustments around the autumn-winter clock change.

Interactions

The other functionally studied OPN4 variant, rs11150800 (Ile394Thr / I394T), has a distinct functional profile: it reduces melanopsin light sensitivity (raises the EC50 threshold) and was specifically associated with reduced pupillary light response in SAD patients in the 2013 study. Since P10L affects amplitude and I394T affects sensitivity, individuals carrying both risk alleles may have compounded impairment of the ipRGC light signaling pathway — though no study has examined the compound genotype directly.

Proposed compound interaction — OPN4 P10L + I394T: Individuals carrying both TT (rs2675703) and the I394T risk genotype (rs11150800) may have doubly impaired melanopsin signaling (reduced amplitude AND reduced sensitivity), potentially requiring more intensive circadian light interventions than either variant alone. No published study addresses this combination, so any combined recommendation is mechanistic extrapolation.